Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2014-06-21
Product name:
NIKKI
DIN:
02416492
Product Monograph/Veterinary Labelling:
Date:
2016-12-20
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
LUPIN LIMITED
Kalpataru Inspire, 3rd Floor, Off Western Highway, Santacruz East
Mumbai
Maharashtra
India
400055
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03AA12 DROSPIRENONE AND ESTROGEN
Active ingredient group (AIG) number:See footnote5
0250430002
| Active ingredient(s) | Strength |
|---|---|
| DROSPIRENONE | 3.0 MG |
| ETHINYL ESTRADIOL | 0.02 MG |